The evolution and interpretation of seroprevalence of SARS-CoV-2 antibodies among South African blood donors from the Beta to Omicron variant-driven waves
- PMID: 38156504
- DOI: 10.1111/vox.13571
The evolution and interpretation of seroprevalence of SARS-CoV-2 antibodies among South African blood donors from the Beta to Omicron variant-driven waves
Abstract
Background and objectives: Confirmed COVID-19 diagnoses underestimate the total number of infections. Blood donors can provide representative seroprevalence estimates, which can be leveraged into reasonable estimates of total infection counts and infection fatality rate (IFR).
Materials and methods: Blood donors who donated after each of three epidemic waves (Beta, Delta and first Omicron waves) were tested for anti-SARS-CoV-2 nucleocapsid antibodies using the Roche Elecsys anti-SARS-CoV-2 total immunoglobulin assay. Roche Elecsys anti-spike antibody testing was done for the post-Omicron sampling. Prevalence of antibodies was estimated by age, sex, race and province and compared to official case reporting. Province and age group-specific IFRs were estimated using external excess mortality estimates.
Results: The nationally weighted anti-nucleocapsid seroprevalence estimates after the Beta, Delta and Omicron waves were 47% (46.2%-48.6%), 71% (68.8%-73.5%) and 87% (85.5%-88.4%), respectively. There was no variation by age and sex, but there were statistically and epidemiologically significant differences by province (except at the latest time point) and race. There was a 13-fold higher seroprevalence than confirmed case counts at the first time point. Age-dependent IFR roughly doubled for every 10 years of age increase over 6 decades from 0.014% in children to 6.793% in octogenarians.
Conclusion: Discrepancies were found between seroprevalence and confirmed case counts. High seroprevalence rates found among Black African donors can be ascribed to historical inequities. Our IFR estimates were useful in refining previous large disagreements about the severity of the epidemic in South Africa. Blood donor-based serosurveys provided a valuable and efficient way to provide near real-time monitoring of the ongoing SARS-CoV-2 outbreak.
Keywords: SARS-CoV-2 antibodies; blood donors; infection fatality rate; seroprevalence.
© 2023 International Society of Blood Transfusion.
Similar articles
-
Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors.Clin Infect Dis. 2021 Jan 27;72(2):249-253. doi: 10.1093/cid/ciaa849. Clin Infect Dis. 2021. PMID: 33501969 Free PMC article.
-
Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey.Int J Epidemiol. 2022 May 9;51(2):404-417. doi: 10.1093/ije/dyab217. Int J Epidemiol. 2022. PMID: 34718591 Free PMC article.
-
Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021.Res Sq [Preprint]. 2021 Feb 12:rs.3.rs-233375. doi: 10.21203/rs.3.rs-233375/v1. Res Sq. 2021. PMID: 33594353 Free PMC article. Preprint.
-
Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors: a systematic review and meta-analysis.BMC Public Health. 2024 Oct 22;24(1):2925. doi: 10.1186/s12889-024-20364-5. BMC Public Health. 2024. PMID: 39438911 Free PMC article.
-
Current challenges of severe acute respiratory syndrome coronavirus 2 seroprevalence studies among blood donors: A scoping review.Vox Sang. 2022 Apr;117(4):476-487. doi: 10.1111/vox.13221. Epub 2021 Dec 3. Vox Sang. 2022. PMID: 34862614
Cited by
-
Estimation of vaccine effectiveness against SARS-CoV-2-associated hospitalization using sentinel surveillance in South Africa.Int J Epidemiol. 2024 Aug 14;53(5):dyae116. doi: 10.1093/ije/dyae116. Int J Epidemiol. 2024. PMID: 39305220 Free PMC article.
References
REFERENCES
-
- Department of Health SA. Department of Health COVID-19 Online Resource and News Portal. Available from: https://sacoronavirus.co.za/covid-19-daily-cases/. Last accessed 8 Dec 2022.
-
- Topol Eric J, Oran Daniel P. The proportion of SARS-CoV-2 infections that are asymptomatic. Ann Intern Med. 2021;174:655-662.
-
- Cheng MP, Papenburg J, Desjardins M, Kanjilal S, Quach C, Libman M, et al. Diagnostic testing for severe acute respiratory syndrome-related coronavirus 2: a narrative review. Ann Intern Med. 2020;172:726-734.
-
- Paton C. The huge gap between excess natural deaths and confirmed COVID-19 deaths may indicate that the latter is under-reported by up to 10 times. Available from: https://www.businesslive.co.za/bd/national/2020-07-23-sa-covid-19-deaths.... Last accessed 12 Dec 2023.
-
- Heever Avd. Lockdown restrictions are not responsible for massive increase in mortality. Ground Up. Available from: https://www.groundup.org.za/author/537/. Last accessed 1 Feb 2021.
MeSH terms
Substances
Supplementary concepts
Grants and funding
- Centre of Excellence grant from the South African Department of Science and Innovation via the National Research Foundation
- 1D43-TW010345/NIH Fogarty International Center training
- 20-ESA011/South African National Blood Service and the Western Cape Blood Service, ELMA South Africa Foundation
- Vitalant Research Institute, San Francisco
- Western Cape Blood Service
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous